MedPath

Scripps Health

Scripps Health logo
🇺🇸United States
Ownership
Private
Established
1924-01-01
Employees
10K
Market Cap
-
Website
http://www.scripps.org

Thoracic Endovascular Repair Versus Open Surgery for Blunt Injury

Withdrawn
Conditions
Blunt Injury
Interventions
Procedure: Open repair of thoracic aorta injury
Procedure: TEVAR
First Posted Date
2013-05-14
Last Posted Date
2016-09-13
Lead Sponsor
Scripps Health
Registration Number
NCT01852773
Locations
🇺🇸

Scripps Mercy Hospital, San Diego, California, United States

Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

Phase 4
Completed
Conditions
Pulmonary Embolism
Deep Vein Thrombosis
Venous Thromboembolic Disease
Interventions
Drug: 30mg enoxaparin Q12 hr
Drug: 5000 Units unfractionated Heparin Q 8 hr
First Posted Date
2012-11-20
Last Posted Date
2016-07-18
Lead Sponsor
Scripps Health
Target Recruit Count
495
Registration Number
NCT01729559
Locations
🇺🇸

Scripps Mercy Hospital, San Diego, California, United States

Unrelated Donor Stem Cell Transplantation

Not Applicable
Completed
Conditions
Acute Lymphoblastic Leukemia
Severe Aplastic Anemia
Chronic Myelogenous Leukemia
Non-Hodgkin's Lymphoma
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Acute Myelogenous Leukemia
Hodgkin's Lymphoma
Large Granulocytic Leukemia
Paroxysmal Nocturnal Hemoglobinuria
Interventions
Procedure: Allogeneic transplantation
First Posted Date
2011-06-02
Last Posted Date
2022-11-23
Lead Sponsor
Scripps Health
Target Recruit Count
64
Registration Number
NCT01364363
Locations
🇺🇸

Scripps Green Hospital, La Jolla, California, United States

Nonmyeloablative Allogeneic Transplant

Not Applicable
Completed
Conditions
Aplastic Anemia
Breast Cancer
Paroxysmal Nocturnal Hemoglobinuria
Acute Myelogenous Leukemia
Sarcoma
Ovarian Cancer
Acute Lymphocytic Leukemia
Myelodysplastic Syndrome
Chronic Myelogenous Leukemia
Chronic Lymphocytic Leukemia
Interventions
Procedure: Nonmyeloablative Allogeneic Transplant
First Posted Date
2011-01-10
Last Posted Date
2022-11-23
Lead Sponsor
Scripps Health
Target Recruit Count
36
Registration Number
NCT01272817
Locations
🇺🇸

Scripps Green Hospital, La Jolla, California, United States

Pilot Study on the Effect of High Clopidogrel Maintenance Dosing

Completed
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2010-05-07
Last Posted Date
2022-11-23
Lead Sponsor
Scripps Health
Target Recruit Count
41
Registration Number
NCT01118793
Locations
🇺🇸

Scripp Health, La Jolla, California, United States

A Trial of Intravesical Therapy for Interstitial Cystitis in Patients With Generalized Vulvodynia

Phase 2
Withdrawn
Conditions
Vulvodynia
Interventions
Drug: Bladder instillation with heparin/ lidocaine
First Posted Date
2010-01-13
Last Posted Date
2022-11-22
Lead Sponsor
Scripps Health
Registration Number
NCT01048177
Locations
🇺🇸

Scripps Clinic, San Diego, California, United States

Genotype Information and Functional Testing Study

Completed
Conditions
Coronary Artery Disease
First Posted Date
2009-10-09
Last Posted Date
2022-11-23
Lead Sponsor
Scripps Health
Target Recruit Count
2000
Registration Number
NCT00992420
Locations
🇺🇸

Scripps Genomic Medicine, La Jolla, California, United States

Muscle Characteristics Associated With Statin Therapy

Not Applicable
Withdrawn
Conditions
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Myopathy
Interventions
First Posted Date
2009-10-07
Last Posted Date
2015-05-22
Lead Sponsor
Scripps Health
Registration Number
NCT00990834
Locations
🇺🇸

Scripps-Mercy Hospital, San Diego, California, United States

Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)

Phase 4
Completed
Conditions
Coronary Artery Disease
Coronary Thrombosis
Interventions
Device: Medtronic Endeavor Stent
Drug: Reduced duration (6 months) DAPT
First Posted Date
2009-08-24
Last Posted Date
2020-10-20
Lead Sponsor
Scripps Health
Target Recruit Count
219
Registration Number
NCT00963781
Locations
🇺🇸

Scripps Clinic, La Jolla, California, United States

The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)

Completed
Conditions
Need for MRI Imaging With Pacemaker or
Implantable Cardioverter Defibrillator Implanted
First Posted Date
2009-05-22
Last Posted Date
2015-11-23
Lead Sponsor
Scripps Health
Target Recruit Count
2039
Registration Number
NCT00907361
Locations
🇺🇸

Northern Indiana Research Alliance, Fort Wayne, Indiana, United States

🇺🇸

UCLA Cardiac Arrhythmia Center, Los Angeles, California, United States

🇺🇸

University of California, San Diego, San Diego, California, United States

and more 18 locations
© Copyright 2025. All Rights Reserved by MedPath